Avalo Therapeutics, Inc.·4

Dec 14, 5:16 PM ET

Harrell James Archie Jr 4

4 · Avalo Therapeutics, Inc. · Filed Dec 14, 2021

Insider Transaction Report

Form 4
Period: 2021-12-10
Harrell James Archie Jr
Exec. VP, Mktg & External Comm
Transactions
  • Purchase

    Common Stock

    2021-12-10$1.57/sh+1,093$1,71636,766 total
Footnotes (1)
  • [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT